$Lineage Cell Therapeutics (LCTX.US)$ Joseph Edelman just purchased 7 million shares. ARVO is May 4-8 FYI
The 41% ManEdelman

$Veru Inc (VERU.US)$ The possibly for a buyout by NVO is plausible and a long play. VERU drug would help with the muscle loss from Ozempic and Wegovy that NVO manufacturers.

$Lineage Cell Therapeutics (LCTX.US)$CNN Report CEO discussed how stem cells are being used for paralized patients.

$Tiziana Life Sciences (TLSA.US)$
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
Thursday, 23rd January at 3:00 pm
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced results from stu...

$Lineage Cell Therapeutics (LCTX.US)$ a reason why Roche is slow walking to trial in my opinion is that they can buy the company on the cheap instead of giving them 18% of the  revenue they deserve…With all the outstanding shares, at a four dollar price tag it would give them a market cap of $1 billion… what would you do if you were Roche?

$Palantir (PLTR.US)$ lets buy

$Palantir (PLTR.US)$ pullback is normal , $70-$75 is cmg
mark my words